Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Accounts receivable allowance $ 4,603 $ 41,401
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, authorized (in shares) 32,659,235 32,659,235
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 700,000,000 700,000,000
Common stock, issued (in shares) 341,474,728 334,030,348
Common stock, outstanding (in shares) 341,474,728 334,030,348
Common stock, subscribed but unissued (in shares) 70,000 0
Series B Convertible Preferred Stock    
Convertible preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Convertible preferred stock, authorized (in shares) 4,908,333 4,908,333
Convertible preferred stock, issued (in shares) 4,908,333 4,908,333
Convertible preferred stock, outstanding (in shares) 4,908,333 4,908,333
Series C Convertible Preferred Stock    
Convertible preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Convertible preferred stock, authorized (in shares) 12,432,432 12,432,432
Convertible preferred stock, issued (in shares) 6,216,216 6,216,216
Convertible preferred stock, outstanding (in shares) 6,216,216 6,216,216